Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Hyperglycemia is a common occurrence in hospitalized patients receiving parenteral and/or enteral nutrition. Although there are several approaches to manage hyperglycemia, there is no consensus on the best practice. We systematically searched PubMed, Embase, Cochrane Central, and ClinicalTrials.gov to identify records (published or registered between April 1999 and April 2019) investigating strategies to manage glucose control in adults receiving parenteral and/or enteral nutrition whilst hospitalized in noncritical care units. A total of 15 completed studies comprising 1170 patients were identified, of which 11 were clinical trials and four observational studies. Diabetes management strategies entailed adaptations of nutritional regimens in four studies, while the remainder assessed different insulin regimens and administration routes. Diabetes-specific nutritional regimens that reduced glycemic excursions, as well as algorithm-driven insulin delivery approaches that allowed for flexible glucose-responsive insulin dosing, were both effective in improving glycemic control. However, the assessed studies were, in general, of limited quality, and we see a clear need for future rigorous studies to establish standards of care for patients with hyperglycemia receiving nutrition support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Profile of fully automated subcutaneous closed-loop insulin delivery over 24 h in a noncritical care patient [31]. A control algorithm modulates subcutaneous insulin delivery via an insulin pump (denoted in blue) according to interstitial sensor glucose values (denoted in red). (Kindly provided by Professor Roman Hovorka, University of Cambridge, UK).](https://figures.cochat.ai/paper-figures/2151112d3a634d7f82a42f0c99e7f913/management-of-glucose-control-in-noncritically-ill-hospitalized-patients-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown potential improvements in detection of glycemic excursions and prevention of hypoglycemia, specifically with the use of glucose telemetry systems.1392–1394”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1392]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · cited 2×
“Table S1 S5: PRISMA 2009 checklist [28], Table S6: MOOSE checklist [29].”
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156 · cited 2×
“2019, Table S5: PRISMA 2009 checklist [28], Table S6: MOOSE checklist [29].”
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“Irrespective to the chosen approach for insulin administration, a limiting factor in obtaining tight glucose control is the risk of inadvertent hypoglycemia [17].”
BackgroundMcCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 1×
“…these patients due to one or more of the following factors: (1) diminished insulin sensitivity due to inflammation, stress hormones, and sedentarism [5]; (2) increased carbohydrate provision [6]; and (3) side-e ff ects of medication such as glucocorticoids that interfere with glucose metabolism [7].”
InfluentialUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 1×
“…these patients due to one or more of the following factors: (1) diminished insulin sensitivity due to inflammation, stress hormones, and sedentarism [5]; (2) increased carbohydrate provision [6]; and (3) side-e ff ects of medication such as glucocorticoids that interfere with glucose metabolism [7].”
InfluentialUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B. (2009) · Digestion · doi:10.1159/000201231 · Cited by 597 · cited 1×
“…these patients due to one or more of the following factors: (1) diminished insulin sensitivity due to inflammation, stress hormones, and sedentarism [5]; (2) increased carbohydrate provision [6]; and (3) side-e ff ects of medication such as glucocorticoids that interfere with glucose metabolism [7].”
InfluentialContinuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward
Turchin, A., Matheny, M. E., Shubina, M., Scanlon, J. V., Greenwood, B., & Pendergrass, M. L. (2009) · Diabetes Care · doi:10.2337/dc08-2127 · Cited by 453 · cited 2×
“As is the case for hyperglycemia, iatrogenic hypoglycemia is associated with increased cost and adverse medical outcomes [16].”
Aragon, D. (2006) · American Journal of Critical Care · doi:10.4037/ajcc2006.15.4.370 · Cited by 370
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270 · cited 2×
“[25].”
Enteral Nutritional Support and Use of Diabetes-Specific Formulas for Patients With Diabetes
Elia, M., Ceriello, A., Laube, H., Sinclair, A. J., Engfer, M., & Stratton, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2267 · Cited by 244 · cited 3×
“Altering the macronutrient distribution (an increase of calories as MUFAs at the expense of carbohydrates) and the use of nonglucose carbohydrate sources along with high fiber content to delay absorption in EN formulae have proven effective in various studies as well as in meta-analyses [22,23].”
Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition
Cheung, N. W., Napier, B., Zaccaria, C., & Fletcher, J. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2367 · Cited by 226
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s015 · Cited by 216
Tappy, L., Schwarz, J.-M., Schneiter, P., Cayeux, C., Revelly, J.-P., Fagerquist, C. K., Jequier, E., & Chiolero, R. (1998) · Critical Care Medicine · doi:10.1097/00003246-199805000-00018 · Cited by 211 · cited 1×
“In critically ill patients, however, lipid-based, compared to iso-energetic glucose-based, PN formulae showed more favorable metabolic effects [51].”
Glycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-Analysis
Murad, M. H., Coburn, J. A., Coto-Yglesias, F., Dzyubak, S., Hazem, A., Lane, M. A., Prokop, L. J., & Montori, V. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2100 · Cited by 192
Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit
Pancorbo‐Hidalgo, P. L., García‐Fernandez, F. P., & Ramírez‐Pérez, C. (2001) · Journal of Clinical Nursing · doi:10.1046/j.1365-2702.2001.00498.x · Cited by 179 · cited 1×
“Indeed, it is estimated that more than 50% of patients on PN and 30% of patients on EN experience hyperglycemia whilst in the hospital [3,4].”
Pasquel, F. J., Gianchandani, R., Rubin, D. J., Dungan, K. M., Anzola, I., Gomez, P. C., Peng, L., Hodish, I., Bodnar, T., Wesorick, D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30402-8 · Cited by 168 · cited 1×
“The recent SITA-HOSPITAL randomized controlled study investigated 279 noncritical care patients with type 2 diabetes and showed that oral sitagliptin plus basal insulin led to similar glycemic control than the more labor-intensive basal–bolus insulin regimen [56].”
MethodDANGERS OF INTRAVENOUS FRUCTOSE
Woods, H. F., & Alberti, K. G. M. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92791-2 · Cited by 166 · cited 2×
“…effects of parenteral xylitol and fructose such as formation of oxalate crystals in the kidney and lactate accumulation [47–49]. to previously reported metabolic side e ff ects of parenteral xylitol and fructose such as formation of oxalate crystals in the kidney and lactate accumulation [47–49].”
Korytkowski, M. T., Salata, R. J., Koerbel, G. L., Selzer, F., Karslioglu, E., Idriss, A. M., Lee, K. K. W., Moser, A. J., & Toledo, F. G. S. (2009) · Diabetes Care · doi:10.2337/dc08-1436 · Cited by 149 · cited 1×
“However, NPH was required in 48% of the control participants, as their glucose levels were not su ffi ciently controlled with the regular sliding scale subcutaneous insulin alone [40].”
Hyperglycemia During Total Parenteral Nutrition
Pasquel, F. J., Spiegelman, R., McCauley, M., Smiley, D., Umpierrez, D., Johnson, R., Rhee, M., Gatcliffe, C., Lin, E., Umpierrez, E., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1748 · Cited by 145 · cited 2×
“Hyperglycemia is frequently encountered during parenteral (PN) and / or enteral (EN) nutrition in hospitalized patients with and without pre-existing diabetes [1,2].”
Boughton, C. K., Bally, L., Martignoni, F., Hartnell, S., Herzig, D., Vogt, A., Wertli, M. M., Wilinska, M. E., Evans, M. L., Coll, A. P., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30061-0 · Cited by 110 · cited 2×
“, 2019 [31] RCT, parallel, two-center 43 Non-T1D surgical and medical PN and/or EN Fully automated s.”
BackgroundSelf-citationOlveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal-Casariego, A., Arraiza-Irigoyen, C., Olivares, J., Conde-García, M. D. C., García-Manzanares, Á., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1379 · Cited by 97
Hyperglycemia Correlates with Outcomes in Patients Receiving Total Parenteral Nutrition
Lin, L., Lin, H., Lin, H.-D., Lee, P.-C., & Ma, W.-Y. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180536b26 · Cited by 96 · cited 1×
“There is an apparently linear relationship between the incidence of adverse outcomes and mean glucose levels once glycaemia surpasses a threshold of 6.3 mM [10].”
InfluentialAhrens, C. L., Barletta, J. F., Kanji, S., Tyburski, J. G., Wilson, R. F., Janisse, J. J., & Devlin, J. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186746.64572.8a · Cited by 93 · cited 1×
“Additionally, lowering the overall carbohydrate and energy provision has proven effective in reducing hyperglycemia in critically ill patients [52,53].”
COMPLICATIONS FOLLOWING INTRAVENOUS ADMINISTRATION OF SOLUTIONS CONTAINING XYLITOL
Thomas, D. W., Edwards, J. B., Gilligan, J. E., LAWRENCE, J. R., & Edwards, R. G. (1972) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1972.tb116530.x · Cited by 76
Hsia, E., Seggelke, S. A., Gibbs, J., Rasouli, N., & Draznin, B. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611420727 · Cited by 62 · cited 1×
“Hypoglycemic events ( 3.9 mM) occurred five times in glargine / lispro group, twice in the twice-daily biphasic group, and once in the thrice-daily biphasic group [45].”
InfluentialLeon-Sanz, M., Garcia-Luna, P. P., Planas, M., Sanz-Paris, A., Gomez-Candela, C., Casimiro, C., & the Abbott SPAI-97-004 Study Cooperative Group (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710502900121 · Cited by 59
Evaluation of the Role of Enteral Nutrition in Managing Patients with Diabetes: A Systematic Review
Ojo, O., & Brooke, J. (2014) · Nutrients · doi:10.3390/nu6115142 · Cited by 58 · cited 3×
“Furthermore, the addition of fibers to EN formulae can delay carbohydrate absorption, thereby attenuating the glycemic impact [22,23].”
Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient
Davidson, P., Kwiatkowski, C. A., & Wien, M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615591057 · Cited by 57 · cited 1×
“Hyperglycemia is frequently encountered during parenteral (PN) and / or enteral (EN) nutrition in hospitalized patients with and without pre-existing diabetes [1,2].”
Marathe, C. S., Rayner, C. K., Bound, M., Checklin, H., Standfield, S., Wishart, J., Lange, K., Jones, K. L., & Horowitz, M. (2014) · Diabetes · doi:10.2337/db13-1757 · Cited by 53
Hyperglycemic Events in Non–Intensive Care Unit Patients Receiving Parenteral Nutrition
Pleva, M., Mirtallo, J. M., & Steinberg, S. M. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609339069 · Cited by 52 · cited 1×
“Indeed, it is estimated that more than 50% of patients on PN and 30% of patients on EN experience hyperglycemia whilst in the hospital [3,4].”
Combining enteral with parenteral nutrition to improve postoperative glucose control
Lidder, P., Flanagan, D., Fleming, S., Russell, M., Morgan, N., Wheatley, T., Rahamin, J., Shaw, S., & Lewis, S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993631 · Cited by 50 · cited 2×
“Four of the clinical trials were considered of medium quality, indicating a low risk of bias in all domains except for performance and detection bias, which was deemed reasonable with a near impossibility of blinding [31–34].”
InfluentialAddition of Insulin to Parenteral Nutrition for Control of Hyperglycemia
McCulloch, A., Bansiya, V., & Woodward, J. M. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117722750 · Cited by 49 · cited 1×
“Insulin can be delivered via intravenous or subcutaneous routes, or in patients receiving PN, insulin may simply be mixed in the nutrition solution [20].”
Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis
Kang, Z.-Q., Huo, J.-L., & Zhai, X. (2018) · Endocrine Connections · doi:10.1530/ec-18-0231 · Cited by 47
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
Bally, L., Thabit, H., & Hovorka, R. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.022 · Cited by 43 · cited 2×
“The combination of real-time glucose measurements from a CGM device with a control algorithm that directs insulin delivery via an insulin pump constitutes a closed-loop system, also known as the artificial pancreas [26,27].”
BackgroundSelf-citationYuan, J., Liu, T., Zhang, X., Si, Y., Ye, Y., Zhao, C., Wang, Q., & Shen, X. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2871-7 · Cited by 39 · cited 2×
“Conversely, treatment of hyperglycemia is shown to improve clinical outcomes [12–15].”
Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
Bally, L., Thabit, H., & Hovorka, R. (2017) · BMC Medicine · doi:10.1186/s12916-017-0794-8 · Cited by 38 · cited 2×
“…from a CGM device with a control algorithm that directs insulin delivery via an insulin pump constitutes a closed-loop system, also known as the artificial pancreas [26, Closed-loop systems automatically adjust insulin delivery every 10–12 min according to real-time glucose measurements.”
Self-citationOlveira, G., Abuín, J., López, R., Herránz, S., García‐Almeida, J. M., García-Malpartida, K., Ferrer, M., Cáncer, E., Pérez, L. M. L., Álvarez, J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.036 · Cited by 38 · cited 1×
“The authors did not provide any details on the requirement for insulin therapy after cessation of nutrition support [32].”
Lee, H., Koh, S. O., & Park, M. S. (2011) · Nutrition Research and Practice · doi:10.4162/nrp.2011.5.5.450 · Cited by 37 · cited 1×
“Additionally, lowering the overall carbohydrate and energy provision has proven e ff ective in reducing hyperglycemia in critically ill patients [52,53].”
Practical handling of AIO admixtures – Guidelines on Parenteral Nutrition, Chapter 10
Mühlebach, S., Franken, C., Stanga, Z. G., & Working Group For Developing The Guidelines For Parenteral Nutrition Of The German Association For Nutritional Medicine (2009) · PubMed Central · doi:10.3205/000077 · Cited by 31
Self-citationEvaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients
Valero, M. A., León-Sanz, M., Escobar, I., Gomis, P., de la Cámara, A., & Moreno, J. M. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601274 · Cited by 31
Hakeam, H. A., Mulia, H. A., Azzam, A. Z., & Amin, T. M. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607116644710 · Cited by 29 · cited 1×
“Mean glucose levels and number of hypoglycemic events did not di ff er between treatment groups [33].”
LACTIC ACIDOSIS AND OSMOTIC DIURESIS PRODUCED BY XYLITOL INFUSION
Thomas, D. W., Gilligan, J. E., Edwards, J. B., & Edwards, R. G. (1972) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1972.tb116531.x · Cited by 28
Kruyt, N. D., Biessels, G. J., Vriesendorp, T. M., DeVries, J. H., Hoekstra, J. B. L., Elbers, P., Kappelle, L. J., Portegies, P., Vermeulen, M., & Roos, Y. B. W. E. M. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9230-z · Cited by 24 · cited 1×
“Compared to a historical control population who received enteral bolus feeds accompanied by intravenous insulin coverage, the intervention resulted in a higher percentage of values in the target range of 4.4–6.1 mM (55% vs. 19%, p 0.005) [39].”
InfluentialInsulin Instability in Parenteral Nutrition Admixtures
Forchielli, M. L., Bongiovanni, F., Platé, L., Piazza, G., Puggioli, C., D'Alise, A., & Bersani, G. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1024 · Cited by 23 · cited 1×
“Furthermore, reservations exist regarding the diminished or highly variable e ffi cacy of PN insulin due to interference from PN ingredients or bag surface material [54,55].”
[The sugar substitutes fructose and sorbite: an unnecessary risk in parenteral nutrition].
Keller, U. B. (1989) · PubMed · Cited by 18
Neff, K., Donegan, D. M., MacMahon, J., O'Hanlon, C., Keane, N., Agha, A., Thompson, C. D., & Smith, D. C. (2014) · PubMed · Cited by 15
Li, F.-F., Zhang, W., Liu, B.-L., Zhang, D., Chen, W., Li, Y., Chen, M.-Y., Zhai, X., Wu, J.-D., Su, X., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24275-5 · Cited by 14 · cited 1×
“No hypoglycemic events occurred in either treatment group [38].”
Hijaze, D., & Szalat, A. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617692765 · Cited by 9 · cited 1×
“Hijaze et al. found comparable mean glucose values, and similar times with glucose values within the target range (7.8–10 mM), in patients receiving subcutaneous NPH insulin thrice daily vs. basal–bolus insulin therapy with insulin analogues [43].”
InfluentialTruong, S., Park, A., Kamalay, S., Hung, N., Meyer, J. G., Nguyen, N. Y., & Momenzadeh, A. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10252 · Cited by 8 · cited 1×
“Additionally, fewer patients receiving insulin via the PN bag experienced two or more hypoglycemic events compared to those with subcutaneous administration (9% vs. 17.1%, p = ns) [42].”
InfluentialBasics in clinical nutrition: Nutritional support in the diabetic patient
Dardai, E. (2009) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2009.06.020 · Cited by 5 · cited 2×
“…supported by the expert group of the European Society of Clinical Nutrition and Metabolism (ESPEN) for patients with a history of diabetes [46]. of diabetes-specific enteral formulae is therefore supported by the expert group of the European Society of Clinical Nutrition and Metabolism…”
Tiyapanjanit, T., & Boonyavarakul, A. (2014) · PubMed · Cited by 5
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Management of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Korytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac278 · Cited by 315
“Benefits and harms The systematic review identified 2 systematic reviews, 1 RCT, and 3 non-RCTs that address this question (11, 98, 101-103).”
BackgroundEfficacy and Efficiency of Nutritional Support Teams
Reber, E., Strahm, R., Bally, L., Schüetz, P., & Stanga, Z. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091281 · Cited by 90
“, blood glucose issues and refeeding syndrome) as well as infections [70].”
BackgroundSelf-citationBarazzoni, R., Bischoff, S. C., Busetto, L., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Genton, L., Schneider, S. M., Singer, P., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.006 · Cited by 70
Metadata
- Authors
- Laesser, C. I., Cumming, P., Reber, E., Stanga, Z., Muka, T., & Bally, L.
- Affiliations
- University of Bern (CH)
- Corresponding author
- Bally, Lia
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-06-28
- Volume
- 8
- Issue
- 7
- Pages
- 935
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC6678336
- OpenAlex
- W2953550627
- Cited by
- 36
- References
- 58
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 3 · 2019: 3
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, glycemic control, parenteral nutrition, enteral nutrition, hospitalized patients, diabetes management, insulin regimens, insulin delivery route, glycemic excursions, nutritional support
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.